At the beginning of the 1970s we began selling medicinal products outside Germany in co-operation with local partner companies. Today, Dr Falk Pharma products are sold in more than 60 countries. Our first subsidiary company abroad was founded in 2001 in Portugal, and we now also have our own subsidiaries in Great Britain / Ireland, Russia, Slovenia, Spain , Benelux and the Ukraine.
As well as marketing established medications, we are also involved in developing new ones. Since the late 1990s we have been working very intensively with partners in Germany, and especially with companies and organisations in the rest of Europe. We work not only on new substances for treating inflammatory bowel diseases and diseases of the liver and pancreas, but also on further development of already approved preparations, for example in the form of new galenic preparations. We are also investigating new applications for products already in use.
In 1995, Ursula Falk, wife of the founder, joined Dr Herbert Falk, who had previously managed the company alone, and became part of the management team. Emphasis will continue to be placed on independence and continuity in the future, too. The tried and tested company philosophy will not be changed. The aim of our family firm is to continue as a niche provider with a slightly different market presence as a balance to the big international pharmaceutical concerns.